Terms: = Uterine cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864 AND Prognosis
13 results:
1. LncRNA MAGI2-As3 Suppresses the Proliferation and Invasion of Cervical cancer by Sponging MiR-15b.
Chai Y; Wang L; Qu Y; Hu Z
J Healthc Eng; 2022; 2022():9707206. PubMed ID: 35126958
[TBL] [Abstract] [Full Text] [Related]
2. [Dysregulation of MAD2L1/CAMK2A/PTTG1 Gene Cluster Maintains the Stemness Characteristics of uterine Corpus Endometrial Carcinoma].
Zheng J; Zhang YW; Pan ZF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Oct; 43(5):685-695. PubMed ID: 34728029
[TBL] [Abstract] [Full Text] [Related]
3. uterine serous carcinoma: key advances and novel treatment approaches.
Ferriss JS; Erickson BK; Shih IM; Fader AN
Int J Gynecol Cancer; 2021 Aug; 31(8):1165-1174. PubMed ID: 34210768
[TBL] [Abstract] [Full Text] [Related]
4. uterine serous carcinoma.
Bogani G; Ray-Coquard I; Concin N; Ngoi NYL; Morice P; Enomoto T; Takehara K; Denys H; Nout RA; Lorusso D; Vaughan MM; Bini M; Takano M; Provencher D; Indini A; Sagae S; Wimberger P; Póka R; Segev Y; Kim SI; Candido Dos Reis FJ; Lopez S; Mariani A; Leitao MM; Raspagliesi F; Panici PB; Di Donato V; Muzii L; Colombo N; Scambia G; Pignata S; Monk BJ
Gynecol Oncol; 2021 Jul; 162(1):226-234. PubMed ID: 33934848
[TBL] [Abstract] [Full Text] [Related]
5. Integrated bioinformatic analysis of miR-15a/16-1 cluster network in cervical cancer.
S S; Shukla V; Khan GN; Eswaran S; Adiga D; Kabekkodu SP
Reprod Biol; 2021 Mar; 21(1):100482. PubMed ID: 33548740
[TBL] [Abstract] [Full Text] [Related]
6. Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer.
Li Y; Li L
BMC Genet; 2020 Sep; 21(1):113. PubMed ID: 32962636
[TBL] [Abstract] [Full Text] [Related]
7. Comparison of laparoscopic and abdominal radical hysterectomy for early stage cervical cancer: oncologic outcomes based on tumor diameter.
He J; Hao M; Liu P; Liu Z; Lang J; Bin X; Chen C
Int J Gynecol Cancer; 2020 Sep; 30(9):1308-1316. PubMed ID: 32699022
[TBL] [Abstract] [Full Text] [Related]
8. Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and prognosis.
Yamada I; Miyasaka N; Kobayashi D; Wakana K; Oshima N; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Eishi Y
Radiol Imaging Cancer; 2019 Nov; 1(2):e190054. PubMed ID: 33778684
[TBL] [Abstract] [Full Text] [Related]
9. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract] [Full Text] [Related]
10. ccne1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
Ayhan A; Kuhn E; Wu RC; Ogawa H; Bahadirli-Talbott A; Mao TL; Sugimura H; Shih IM; Wang TL
Mod Pathol; 2017 Feb; 30(2):297-303. PubMed ID: 27767100
[TBL] [Abstract] [Full Text] [Related]
11. Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.
Shoji T; Takatori E; Furutake Y; Takada A; Nagasawa T; Omi H; Kagabu M; Honda T; Miura F; Takeuchi S; Kumagai S; Yoshizaki A; Sato A; Sugiyama T
Int J Clin Oncol; 2016 Dec; 21(6):1120-1127. PubMed ID: 27342833
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemical Profiling of Endometrial Serous Carcinoma.
Chen W; Husain A; Nelson GS; Rambau PF; Liu S; Lee CH; Lee S; Duggan MA; Köbel M
Int J Gynecol Pathol; 2017 Mar; 36(2):128-139. PubMed ID: 27167671
[TBL] [Abstract] [Full Text] [Related]
13. Serum YKL-40 as a marker for cervical adenocarcinoma.
Mitsuhashi A; Matsui H; Usui H; Nagai Y; Tate S; Unno Y; Hirashiki K; Seki K; Shozu M
Ann Oncol; 2009 Jan; 20(1):71-7. PubMed ID: 18723551
[TBL] [Abstract] [Full Text] [Related]
